Education only. Not medical advice No products sold here For research & informational use
Field GuideAnti-Aging & SkinAHK-Cu
Anti-Aging & Skin

AHK-Cu

copper tripeptide-1 · the hair one

A copper-binding tripeptide — GHK-Cu's less famous sibling, with the research pointed at hair follicles rather than skin. Almost entirely a topical compound, whatever the vial suggests.

📝 Community guide · reviewed by Carl · Suggest an edit
Carl reading the research Carl read the papers
so you don’t have to.

What it actually is

AHK-Cu is the tripeptide alanine-histidine-lysine bound to copper. It sits alongside GHK-Cu in the copper peptide family, sharing the same basic idea: a short peptide that carries copper into tissue, where copper acts as a cofactor in a range of repair enzymes.

Where GHK-Cu's research is largely about skin — collagen, wound healing, remodelling — AHK-Cu's is pointed at hair follicles. The patent literature on peptide copper complexes for hair growth is the most substantial part of its file.

Carl’s one-liner: GHK-Cu's cousin, aimed at the scalp. Interesting patents, thin human data, and a dosing convention borrowed rather than established.

How it’s thought to work

What the research says

Modest and largely preclinical. There is a real patent literature on peptide copper complexes for stimulating hair growth, and in vitro work on tripeptide-copper effects on human hair follicles. Animal work found that AHK-Cu injection produced hair retention in roughly a 0.25 cm radius around the injection site, most clearly in the 0.1–0.5 mg dose range — a very local effect. Human clinical dose-finding has not been done.

Watch: AHK-Cu explained

Video by Kevin Li on YouTube. Not affiliated with Peptide Carl and not an endorsement — included because a second explanation of the same mechanism is often what makes it click.

Reported protocols

These are the doses the peptide community actually reports running (Reddit & forums), alongside published research — logged for education, not as a recommendation to use.

ParameterCommonly reported range
Topical serumThe common form — roughly 1–2 mg/mL, about 0.1–0.2%, applied to the scalp
FrequencyOnce or twice daily is the most commonly reported cadence
Reconstitution for topical useA 20 mg vial into 10–20 mL of carrier gives roughly the 1–2 mg/mL range
InjectionAnimal work used 0.1–0.5 mg locally; the effect was confined to a small radius around each site
TimelineHair responds on follicle cycle time — 3–6 months before anything is assessable
Community tipThe consistent point is that this is a topical compound. The vial format invites injection, but the animal data showed the effect was local to a quarter-centimetre around each site — which for a whole scalp is not a practical protocol.
Reality check: AHK-Cu has no established human dosing protocol. The concentrations quoted above come from community formulations and from its family resemblance to GHK-Cu, not from human dose-finding. Copper peptides are also incompatible with several common actives — direct-acid vitamin C in particular — which is a formulation problem people run into constantly. And copper is not something to load indefinitely; these are meant to be applied at low concentration, not accumulated.

Common use cases

GoalCommunity protocol notes
Scalp / hair support1–2 mg/mL topical serum, once or twice daily, assessed at 3–6 months
Alongside GHK-Cuthe family pairing — follicles and skin respectively
Why not injectionthe animal effect was confined to ~0.25 cm around each site

Mixing it (reconstitution)

Freeze-dried peptides must be reconstituted with bacteriostatic water before they can be measured. Carl’s calculator turns “mg in the vial + ml of water + target dose” into “units on the syringe” — and tells you how long the vial lasts.

→ Open the Reconstitution Calculator

Injection & handling

In practice this is a topical compound rather than an injected one. The usual approach is to reconstitute into a carrier at roughly 1–2 mg/mL — a 20 mg vial into 10–20 mL — and apply to the scalp once or twice daily. The animal injection data is the reason topical wins: hair retention appeared only within about a quarter of a centimetre of each injection site, so covering a scalp by injection is not realistic. Keep copper peptides away from direct-acid vitamin C in a routine, and expect to wait three to six months before there is anything to assess.

Stacks it appears in

Carl’s quick FAQ

Topical or injected?
Topical, in practice. The animal injection work showed hair retention only within about 0.25 cm of each injection site, which does not scale to a scalp.
How is this different from GHK-Cu?
Different tripeptide, same copper-carrying principle. GHK-Cu's research base is skin and wound healing; AHK-Cu's is hair follicles. GHK-Cu is much better studied overall.
What concentration should a serum be?
Community formulations generally land around 1–2 mg/mL — roughly 0.1–0.2%. This is a convention rather than a clinically established figure.
How long before anything shows?
Hair works on follicle cycle time. Three to six months is the realistic window before there is anything to judge.
The honest summary: The weakest evidence base of the copper peptides, and often bought on GHK-Cu's reputation rather than its own. The patent literature and in vitro work are genuinely interesting; the human data is essentially absent, and every concentration figure in circulation is borrowed or self-reported. If you want a copper peptide with an actual research file behind it, GHK-Cu is the one — AHK-Cu is the more speculative bet aimed at a different tissue.
Carl
📩 The Field Notes

Liked this breakdown?

Carl sends one like it every week — plus the free Beginner’s Field Notes PDF. Plain English, zero hype, unsubscribe anytime.

Free. We’ll never sell your email. Education only — not medical advice.
RELATED

Keep reading